IGFBP6 anticorps (AA 141-240) (FITC)

N° du produit ABIN753305

L’anticorps Lapin Polyclonal anti-IGFBP6 a été validé pour WB, IF (cc) et IF (p). Il convient pour détecter IGFBP6 dans des échantillons de Souris et Rat.

Aperçu rapide pour IGFBP6 anticorps (AA 141-240) (FITC) (ABIN753305)

Antigène: IGFBP6 (Insulin-Like Growth Factor Binding Protein 6 (IGFBP6))

Reactivité: Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp IGFBP6 est conjugé à/à la FITC

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Détail du produit anti-IGFBP6 anticorps (FITC)

Épitope: AA 141-240

Réactivité croisée: Souris, Rat

Homologie: Human,Dog,Cow,Sheep,Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human IGFBP6

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur IGFBP6

Antigène: IGFBP6 (Insulin-Like Growth Factor Binding Protein 6 (IGFBP6))

Autre désignation: IGFBP6

Sujet:

Synonyms: IBP6, Insulin-like growth factor-binding protein 6, IBP-6, IGF-binding protein 6, IGFBP-6, IGFBP6

Background: IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors.

ID gène: 3489

UniProt: P24592

Pathways: Signalisation WNT, Myometrial Relaxation and Contraction